Truvestments Capital’s ESSA Pharma EPIX Stock Holding History

Truvestments Capital’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-490	Closed	-$94	–	1066
2025 Q3	$94	Sell	490 -3,198	-87%	-$3.83K	﹤0.01%	1001
2025 Q2	$6.27K	Hold	3,688	–	–	﹤0.01%	710
2025 Q1	$5.83K	Sell	3,688 -253	-6%	-$428	﹤0.01%	738
2024 Q4	$7.05K	Buy	3,941 +3,095	+366%	+$9.86K	﹤0.01%	654
2024 Q3	$5.13K	Buy	+846	New	+$4.65K	﹤0.01%	683

Truvestments Capital's EPIX Position: Q4 2025 in Review

Truvestments Capital sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 490 shares — an estimated $94 sold.

Truvestments Capital first reported a position in EPIX in Q3 2024 and held it in 5 quarters. The position peaked at $7.05K in Q4 2024. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

Truvestments Capital reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
Truvestments Capital sold 490 ESSA Pharma shares in Q4 2025, an estimated $94.
Truvestments Capital first reported a position in ESSA Pharma in Q3 2024 and held it in 5 quarters.
Truvestments Capital's ESSA Pharma position peaked at $7.05K in Q4 2024.
0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on Truvestments Capital's 13F filing for Q4 2025, filed 13 Feb 2026.